Publishing research using ab108529? Please let us know so that we can cite the reference in this datasheet.
ab108529 has been referenced in 8 publications.
- Giuliano CJ et al. MELK expression correlates with tumor mitotic activity but is not required for cancer growth. Elife 7:N/A (2018). PubMed: 29417930
- Li Y et al. MicroRNA-214-3p inhibits proliferation and cell cycle progression by targeting MELK in hepatocellular carcinoma and correlates cancer prognosis. Cancer Cell Int 17:102 (2017). WB, IHC-P ; Human . PubMed: 29151817
- Takeuchi H et al. Phosphorylation of the HIV-1 capsid by MELK triggers uncoating to promote viral cDNA synthesis. PLoS Pathog 13:e1006441 (2017). WB . PubMed: 28683086
- Lin A et al. CRISPR/Cas9 mutagenesis invalidates a putative cancer dependency targeted in on-going clinical trials. Elife 6:N/A (2017). PubMed: 28337968
- Huang HT et al. MELK is not necessary for the proliferation of basal-like breast cancer cells. Elife 6:N/A (2017). WB ; Human . PubMed: 28926338
- Wang Y et al. Mitotic MELK-eIF4B signaling controls protein synthesis and tumor cell survival. Proc Natl Acad Sci U S A 113:9810-5 (2016). PubMed: 27528663
- Wang Y et al. MELK is an oncogenic kinase essential for mitotic progression in basal-like breast cancer cells. Elife 3:e01763 (2014). Human . PubMed: 24844244
- Kig C et al. Maternal embryonic leucine zipper kinase (MELK) reduces replication stress in glioblastoma cells. J Biol Chem 288:24200-12 (2013). WB ; Human . PubMed: 23836907